| Farnesoid X receptor deficiency in mice leads to increased intestinal epithelial cell proliferation and tumor development RRM Maran, A Thomas, M Roth, Z Sheng, N Esterly, D Pinson, X Gao, ... Journal of Pharmacology and Experimental Therapeutics 328 (2), 469-477, 2009 | 246 | 2009 |
| Farnesoid X receptor deficiency in mice leads to increased intestinal epithelial cell proliferation and tumor development RRM Maran, A Thomas, M Roth, Z Sheng, N Esterly, D Pinson, X Gao, ... Journal of Pharmacology and Experimental Therapeutics 328 (2), 469-477, 2009 | 246 | 2009 |
| Genome‐wide tissue‐specific farnesoid X receptor binding in mouse liver and intestine AM Thomas, SN Hart, B Kong, J Fang, X Zhong, GL Guo Hepatology 51 (4), 1410-1419, 2010 | 210 | 2010 |
| A decision support framework for genomically informed investigational cancer therapy F Meric-Bernstam, A Johnson, V Holla, AM Bailey, L Brusco, K Chen, ... Journal of the National Cancer Institute 107 (7), djv098, 2015 | 199 | 2015 |
| Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol F Meric-Bernstam, L Brusco, M Daniels, C Wathoo, AM Bailey, L Strong, ... Annals of Oncology 27 (5), 795-800, 2016 | 182 | 2016 |
| ALK: a tyrosine kinase target for cancer therapy VR Holla, YY Elamin, AM Bailey, AM Johnson, BC Litzenburger, ... Molecular Case Studies 3 (1), a001115, 2017 | 172 | 2017 |
| The Chelsea critical care physical assessment tool (CPAx): validation of an innovative new tool to measure physical morbidity in the general adult critical care population; an … EJ Corner, H Wood, C Englebretsen, A Thomas, RL Grant, D Nikoletou, ... Physiotherapy 99 (1), 33-41, 2013 | 165 | 2013 |
| Nontuberculous mycobacterial disease following hot tub exposure. EJ Mangione, G Huitt, D Lenaway, J Beebe, A Bailey, M Figoski, MP Rau, ... Emerging infectious diseases 7 (6), 1039, 2001 | 155 | 2001 |
| Increased activation of the Wnt/β-catenin pathway in spontaneous hepatocellular carcinoma observed in farnesoid X receptor knockout mice A Wolfe, A Thomas, G Edwards, R Jaseja, GL Guo, U Apte Journal of Pharmacology and Experimental Therapeutics 338 (1), 12-21, 2011 | 131 | 2011 |
| 1-Deoxy-d-Xylulose 5-Phosphate Reductoisomerase (IspC) from Mycobacterium tuberculosis: towards Understanding Mycobacterial Resistance to Fosmidomycin RK Dhiman, ML Schaeffer, AM Bailey, CA Testa, H Scherman, DC Crick Journal of bacteriology 187 (24), 8395-8402, 2005 | 120 | 2005 |
| Amphotericin B and fluconazole, a potent combination therapy for cryptococcal meningitis RA Larsen, M Bauer, AM Thomas, JR Graybill Antimicrobial agents and chemotherapy 48 (3), 985-991, 2004 | 109 | 2004 |
| FXR silencing in human colon cancer by DNA methylation and KRAS signaling AM Bailey, L Zhan, D Maru, I Shureiqi, CR Pickering, G Kiriakova, J Izzo, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 306 (1 …, 2014 | 81 | 2014 |
| Implementation of biomarker-driven cancer therapy: existing tools and remaining gaps AM Bailey, Y Mao, J Zeng, V Holla, A Johnson, L Brusco, K Chen, ... Discovery medicine 17 (92), 101, 2014 | 80 | 2014 |
| Dose‐response impact of various tocotrienols on serum lipid parameters in 5‐week‐old female chickens SG Yu, AM Thomas, A Gapor, B Tan, N Qureshi, AA Qureshi Lipids 41 (5), 453, 2006 | 75 | 2006 |
| Amphotericin B colloidal dispersion combined with flucytosine with or without fluconazole for treatment of murine cryptococcal meningitis DAM Diamond, M Bauer, BE Daniel, MAE Leal, D Johnson, BK Williams, ... Antimicrobial agents and chemotherapy 42 (3), 528-533, 1998 | 71 | 1998 |
| Precision oncology decision support: current approaches and strategies for the future KC Kurnit, EEI Dumbrava, B Litzenburger, YB Khotskaya, AM Johnson, ... Clinical Cancer Research 24 (12), 2719-2731, 2018 | 68 | 2018 |
| Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignancies MJ Reilley, A Bailey, V Subbiah, F Janku, A Naing, G Falchook, D Karp, ... Journal for immunotherapy of cancer 5, 1-10, 2017 | 66 | 2017 |
| Identification, cloning, purification, and enzymatic characterization of Mycobacterium tuberculosis 1-deoxy-d-xylulose 5-phosphate synthase AM Bailey, S Mahapatra, PJ Brennan, DC Crick Glycobiology 12 (12), 813-820, 2002 | 66 | 2002 |
| The right drugs at the right time for the right patient: the MD Anderson precision oncology decision support platform A Johnson, J Zeng, AM Bailey, V Holla, B Litzenburger, H Lara-Guerra, ... Drug discovery today 20 (12), 1433-1438, 2015 | 63 | 2015 |
| Molecular Landscape of ERBB2/ERBB3 Mutated Colorectal Cancer JM Loree, AM Bailey, AM Johnson, Y Yu, W Wu, CA Bristow, JS Davis, ... JNCI: Journal of the National Cancer Institute 110 (12), 1409-1417, 2018 | 61 | 2018 |
